Precision Medicine News and Research

RSS

Evergreen Life spearheads the drive for everyone to have access to personal health data

Recent media reports have focused on the prospect that US businesses may want to buy patient data from the NHS.

From Evergreen Life 6 Dec 2019

Coriell scientist awarded grant to explore epigenetic drivers of breast cancer

Shoghag Panjarian, PhD, a research scientist at the Coriell Institute for Medical Research, has been awarded a grant from the W. W. Smith Charitable Trust to support her search for epigenetic factors that contribute to the development and growth of breast cancer.

5 Dec 2019

GW-led consortium receives $2.2 million from FDA for Biocompute Object Specification Project

A consortium led by the George Washington University (GW) has been refunded for their BioCompute Object Specification Project, thanks to a $2.2 million, five-year grant from the U.S. Food and Drug Administration.

4 Dec 2019

FDA-approved drug repairs gut leakiness associated with ulcerative colitis

A research team led by biomedical scientists at the University of California, Riverside, has found that a drug approved by the FDA to treat rheumatoid arthritis and ulcerative colitis can repair permeability defects in the gut's epithelium.

4 Dec 2019

New human colon-on-a-chip enables in vitro study of mucus physiology

We have a mutualistic but complicated relationship with the collection of microbes in our gut known as the intestinal microbiome.

3 Dec 2019

New computational method can help predict and design allosteric functions in proteins

Called the "second secret of life", allostery is one of the most fundamental processes of biology and has been a central focus among scientists across the life sciences spectrum, from fundamental biology to drug development.

3 Dec 2019

Coriell Institute for Medical Research wins $7.7 million NINDS contract

Coriell Institute for Medical Research has been awarded a $7.7 million contract by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health focused on the study of nervous system disorders.

21 Nov 2019

Omega 3 fish oil supplements may benefit some children with ADHD

A team of researchers from King's College London collaborated with colleagues from China Medical University in Taichung, Taiwan to find that omega-3 fish oil supplements could benefit children with Attention Deficit Hyperactivity Disorder (ADHD). Their work was published in the latest issue of the journal Translational Psychiatry.

20 Nov 2019

New gene mutation involved in familial thyroid cancers identified

Researchers from Penn State College of Medicine identified a new gene mutation that may cause a type of familial thyroid cancer.

20 Nov 2019

New computational model could help in the development of anti-cancer drugs

Researchers from the Faculty of Medicine and the Institute for Molecular Medicine at the University of Helsinki have developed a computational model, Combined Essentiality Scoring (CES) that enables accurate identification of essential genes in cancer cells for development of anti-cancer drugs.

14 Nov 2019

2D barcoded tubes for sample storage at ultra-low temperatures

The Ziath range of CryzoTraq 2D-barcoded cryogenic tubes set a new standard for cryogenic storage of biological specimens at temperatures as low as -196 °C.

From Ziath Ltd 14 Nov 2019

'Smart toilets' may work as real-time method of monitoring health

Wearable, smart technologies are transforming the ability to monitor and improve health, but a decidedly low-tech commodity - the humble toilet - may have potential to outperform them all.

13 Nov 2019

First comprehensive characterization of blood-brain, blood-tumor barriers in brain metastases

The human brain has some remarkable capabilities - including the ability to block cancer drugs from effectively reaching cancer cells in the brain.

12 Nov 2019

Simulation-based approach to target epilepsy enters into clinical trial

In what represents a major milestone on the path to clinical application, a novel method to improve outcomes of Epilepsy surgery has now received approval for clinical testing in 13 French hospitals.

9 Nov 2019

Hitachi and CLB in Lyon-France announce research collaboration to fight against cancer with AI

Hitachi, Ltd. and Centre Leon Berard (CLB), a leading French Comprehensive Cancer Center in Lyon-France, announced today that they have entered into an agreement to jointly promote research and development aimed at improving the efficiency of diagnosis and treatment of cancer and established a new research laboratory called Hitachi Lyon Lab on the CLB site, starting November 5th.

8 Nov 2019

New method to construct personalized gene networks may contribute to personalized treatments

Researchers at Penn State College of Medicine have developed a new method to model how genes interact with each other -- and it may someday contribute to the development of personalized treatments for patients.

7 Nov 2019

Hitachi and CLB establish new research laboratory to improve diagnosis, treatment of cancer

Hitachi, Ltd. and Centre Leon Berard, a leading French Comprehensive Cancer Center in Lyon-France, announced today that they have entered into an agreement to jointly promote research and development aimed at improving the efficiency of diagnosis and treatment of cancer and established a new research laboratory called Hitachi Lyon Lab on the CLB site, starting November 5th.

6 Nov 2019

New deep learning tool will advance personalized medicine for musculoskeletal diseases

Personalized medicine has stirred the imagination of drugs and therapies that are individually tailored to patients.

31 Oct 2019

Dartmouth scientist awarded grant to build new AI technologies for lung cancer management

Lung cancer is the second most common type of cancer and leading cause of cancer death in men and women, with non-small cell lung cancer (NSCLC) accounting for up to 90% of cases. Somatic mutations heavily impact the sensitivity of NSCLC patients to various drug treatments, and are critical for choosing the most effective targeted therapies for this cancer.

23 Oct 2019

Development and assessment of NGS-based microsatellite instability assay

The assay has a clinically relevant five-day turnaround time and can be conducted on as little as 20 ng genomic DNA with a batch size of up to forty samples in a single run.

18 Oct 2019